Drug-drug interaction study to investigate the effect of finerenone on warfarin
The primary objective of this study was to investigate whether, with respect to warfarin, there is any pharmacodynamic or pharmacokinetic interaction when finerenone and warfarin are co-administered in healthy subjects.
The secondary objectives were the investigation of the pharmacokinetics of finerenone alone and after concomitant administration with warfarin, as well as the assessment of safety and tolerability of these treatments.
- Healthy White male subjects 18-45 years of age (inclusive)
No Exclusion Criteria Available
Berlin, Germany, 13353
E-mail: [email protected]
Phone: (+)1-888-84 22937
Randomized, double-blind, placebo-controlled, 2-fold cross-over study to investigate the effects of finerenone, administered as 20 mg IR tablets once-daily over 6 days, on the safety, tolerability, pharmacodynamics and pharmacokinetics of warfarin in healthy male subjects